CRISPR-Cas

Phage-Powered Evolution Unleashes Compact and Mighty Prime Editors

CRISPR-Cas, GENETICS, INNOVATION, NEWS, PHAGE TECHNOLOGY

In the mesmerizing world of genetic engineering, prime editing has emerged as a shining star,...
Read More

CRISPR-based Phage Therapy Shines in the First Human Trial

Clinical trial, CRISPR-Cas, NEWS

SNIPR Biome, a Danish microbiome technology company, has unveiled promising results from the initial phase of their groundbreaking...
Read More

Revolutionizing Infection Treatment: SNIPR Biome’s CRISPR-armed Phage Therapy Targets Antibiotic-Resistant E. Coli in Gut

CRISPR-Cas, PHAGE TECHNOLOGY, PHAGE THERAPY

SNIPR Biome ApS has made a groundbreaking discovery in the field of microbiology, paving the way for a new era of microbial gene therapy....
Read More

Jumbo phage chimallin (ChmA) protein: The answer to CRISPR-Cas bacterial defense system?

CRISPR-Cas, JUMBO PHAGES, PHAGE RESISTANCE, PHAGE THERAPY, RESEARCH

Loughlin et, 2020 Jumbo phages are bacteriophages (phages) with genetic information (genomes)...
Read More
Close